Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up
(a) Long-term mean BCVA change from baseline. (b) Mean BCVA change from baseline according to previous treatment status. Note: variance is expressed in form of standard error of the mean; data depicted as dotted lines must be interpreted with caution as it represents a sample size of n < 30. ETDRS and Snellen equivalents were calculated from LogMAR values.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.